SpringerLink
Log in

Is There Saturation in the Conversion of Baicalein to Baicalin After Oral Chewable Tablets: Retrospective Evaluation of the Human Pharmacokinetic Data?

  • Letter to the Editor
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

The Original Article was published on 28 June 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Lee E, Park HR, Ji ST, Lee Y, Lee J. Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson’s disease model by down regulating the activations of nuclear factor-κB, ERK, and JNK. J Neurosci Res. 2014;92(1):130–9.

    Article  CAS  PubMed  Google Scholar 

  2. Hu Q, Uversky VN, Huang M, Kang H, Xu F, Liu X, et al. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson’s disease. Biochim Biophys Acta. 2016;1862(10):1883–90.

    Article  CAS  PubMed  Google Scholar 

  3. Gao L, Li C, Yang RY, Lian WW, Fang JS, Pang XC, et al. Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson’s disease: a microarray study. Pharmacol Biochem Behav. 2015;133:155–63.

    Article  CAS  PubMed  Google Scholar 

  4. Donald G, Hertzer K, Eibl G. Baicalein: an intriguing therapeutic phytochemical in pancreatic cancer. Curr Drug Targets. 2012;13(14):1772–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. de Oliveira MR, Nabavi SF, Habtemariam S, Erdogan Orhan I, Daglia M, Nabavi SM. The effects of baicalein and baicalin on mitochondrial function and dynamics: a review. Pharmacol Res. 2015;100:296–308.

    Article  CAS  PubMed  Google Scholar 

  6. Pang H, Xue W, Shi A, Li M, Li Y, Cao G, et al. Multiple-ascending-dose pharmacokinetics and safety evaluation of baicalein chewable tablets in healthy chinese volunteers. Clin Drug Investig. 2016;36(9):713–24.

    Article  CAS  PubMed  Google Scholar 

  7. Srinivas NR. Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica. 2010;40(5):357–67.

    Article  CAS  PubMed  Google Scholar 

  8. Noh K, Kang Y, Nepal MR, Jeong KS, Oh do G, Kang MJ, et al. Role of intestinal microbiota in baicalin-induced drug interaction and its pharmacokinetics. Molecules. 2016;21:337.

    Article  CAS  PubMed  Google Scholar 

  9. Kang MJ, Ko GS, Oh DG, Kim JS, Noh K, Kang W, et al. Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin. Arch Pharm Res. 2014;37(3):371–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The contents of the manuscript (ZRC publication no. 501) was prepared on the basis of scientific curiosity.

Author information

Authors and Affiliations

  1. Zydus Research Center, Sarkhej-Bavla NH 8A, Moraiya, Ahmedabad, Gujarat, 382 210, India

    Nuggehally R. Srinivas

Authors
  1. Nuggehally R. Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuggehally R. Srinivas.

Ethics declarations

Conflict of interest

Nuggehally R. Srinivas is an employee of Cadila Health Care Ltd, Ahmedabad, India. The author has no conflicts of interest to declare.

Funding

No exteranl sources of funding were used for the preparation of this letter.

Additional information

This Letter to the Editor is related to the original article available at doi:10.1007/s40261-016-0418-7.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Srinivas, N.R. Is There Saturation in the Conversion of Baicalein to Baicalin After Oral Chewable Tablets: Retrospective Evaluation of the Human Pharmacokinetic Data?. Clin Drug Investig 36, 1075–1076 (2016). https://doi.org/10.1007/s40261-016-0467-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-016-0467-y

Keywords

Search

Navigation